Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRC

NCT02024412 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: monosialotetrahexosylganglioside Sodium
OTHER: placebo

Sponsor

Tianjin Medical University Cancer Institute and Hospital